BioCentury
ARTICLE | Financial News

Novavax prices $50M follow-on

April 13, 2018 5:20 PM UTC

Infectious disease company Novavax Inc. (NASDAQ:NVAX) raised $50 million after hours on April 11 through the sale of 30.3 million shares at $1.65 in a follow-on underwritten by Citigroup, Piper Jaffr...

BCIQ Company Profiles

Novavax Inc.